A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway
PHASE1
The primary objective of the study is to evaluate the safety, tolerability,...
Testing the Effectiveness of Mainstream Management Tools to Increase Organizational Commitment and Job Satisfaction and Decrease Turnover Among Peer Providers
NA
The role of peer support specialists (PSS) has burgeoned in the mental heal...
A Study to Investigate the Efficacy and Safety of Two Doses of GSK2857916 in Participants With Multiple Myeloma Who Have Failed Prior Treatment With an Anti-CD38 Antibody
PHASE2
Multiple myeloma (MM) is an incurable malignancy and accounts for 1 percent...